ArticleColombia medica (Cali, Colombia)
Factors influencing COVID-19 vaccination acceptance when knowing potential side effects: a study in Colombia.
Article in Colombia medica (Cali, Colombia). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To examine the determinants of COVID-19 vaccine acceptance in Colombia, with particular emphasis on individuals' responses to possible side effects. Methods: A cross-sectional study was conducted using an anonymous online questionnaire in Colombia between January and March 2023. The Results: The 40.2% of respondents expressed doubts or would have rejected vaccination had they known about possible side effects beforehand. Women were more likely to hold doubts or reject the vaccine after experiencing adverse effects. Participants who experienced side effects were more likely to question their decision to vaccinate. Younger individuals were less likely than older adults to develop negative attitudes after experiencing side effects. Those who had received only one dose were more likely to doubt or reject further vaccination, whereas individuals with multiple doses were less likely to do so. Participants with asymptomatic COVID-19 were less likely to refuse vaccination after learning about potential side effects, possibly because they trusted their immune system more or had a stronger desire to protect others. Conclusions: Vaccination hesitancy was associated with female sex, prior adverse effects, and fewer doses, whereas younger age was associated with greater acceptance. These findings highlight the need for targeted risk communication to address safety concerns and strengthen vaccine confidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.